Build Your Dream Project Now Hire Us

Our Global Presence:

Enterprise AI · AI Automation · Since 2013

AI that does the work, not just the demo.

Quest GLT builds AI systems that live inside your real workflows — drafting, checking, routing, and logging — so your people only touch the decisions that need human judgment. We've been shipping enterprise software for Fortune 500 clients since 2013. AI is the newest tool in the box, not the first.

Agentic AI
Plans · Acts · Executes
Autonomous AI agents that complete real business tasks end to end.
Generative AI
Creates · Drafts · Responds
Enterprise-grade content generation with compliance guardrails.
QUEST AI
ENGINE
Real Business Execution
Predictive AI
Forecasts · Detects · Optimizes
Identifies risks and opportunities before they surface.
Enterprise Integration
Connects · Routes · Synchronizes
Works across CRM, ERP, databases, APIs, and workflows.

What we build

The Quest AI capability chain

Agentic AI

Workflows that complete multi-step processes end to end

Generative AI

Content engines with compliance guardrails baked in

AI Assistants

Trained on your data, not the open internet

Predictive Analytics

Flags risk before it costs you

Enterprise Integrations

Across Veeva, Salesforce, SAP, Oracle & more

EST. 2013 · USA · UAE · CANADA · INDIA

AI services

Six ways we put AI to work inside your business

Every engagement starts with the same question: which repetitive, expensive, error-prone process should stop being manual first? Then we build for that — not for a slide deck.

Agentic AI & workflow automation

AI agents that handle multi-step work — draft, validate, route, log — across your existing systems. Humans approve; agents execute. This is the architecture behind our Teva engagement below.

For: ops-heavy teams drowning in handoffs

Generative AI content systems

Content engines that draft emails, documents, slides, and training material from your approved libraries — contextualized by region, segment, or product line, with version control built in.

For: marketing & medical content at scale

AI compliance & guardrails

Automated pre-checks for prohibited terms, policy violations, and missing references — plus audit trails that log every change for regulators. Built for FDA, EMA, and GDPR environments.

For: regulated industries — pharma, finance, health

Custom AI assistants & chatbots

Assistants trained on your knowledge base for HCP query management, internal support, and customer service — with escalation rules so the hard questions still reach a human.

For: support teams & field-facing roles

Predictive analytics & insights

Models that anticipate compliance risk before submission, forecast engagement, and surface what your dashboards currently tell you three weeks too late.

For: leadership teams who hate surprises

Enterprise AI integration

The unglamorous part that makes everything else work: connecting AI with Veeva, Salesforce, SAP, Oracle, SharePoint, Okta, Power BI, and Tableau so nothing waits on a copy-paste.

For: CIOs tired of disconnected pilots

Featured case study · Sept 2025

Teva Pharmaceuticals: pharma content in days, not quarters

Teva went looking for a way out of multi-week content review cycles on Veeva CRM. We designed an agentic AI layer that drafts, pre-checks, and routes compliant content before a human reviewer ever opens it — starting with a contained pilot in one business unit.

Pilot Impact — Projected Outcomes · Teva Pharmaceuticals

01
40–50%
Cycle Reduction

MLR approvals in weeks, not months

Workflow acceleration
02
2–3wks
Faster Launches

Content live before market windows close

Speed to market
03
$200K
Annual Savings

Projected per business unit, pilot alone

Operational efficiency
04
$1M+
Revenue Impact

Per week saved on a high-value launch

Business growth

The challenge

Robust processes. Painfully slow ones.

Teva's Veeva CRM workflows weren't broken. They were built for a different era — one where a marketing email could afford to sit in review queues for weeks while competitors moved.

Every HCP email, CLM slide, and detailing aid moved through medical, legal, and regulatory (MLR) review by hand. Reviewers read full documents line by line. Teams worked in sequence, not in parallel. And in the generics business, weeks lost in review aren't an inconvenience — they're erosion risk, with every delayed launch handing margin to whoever ships first.

Manual re-submissions added audit-finding risk on top. The cost wasn't just time; it was missed windows, regulator exposure, and a content ops budget that grew with headcount instead of output.

  • Multi-week MLR cycles on standard promotional content — approvals measured in months
  • Speed-to-market losses — generics facing erosion risk with every week stuck in review
  • Manual re-submissions driving audit-finding risk and reviewer fatigue
  • Adoption challenges from past tooling rolled out without change management
  • Falling behind peers — Pfizer, Novartis, and Sanofi already scaling AI workflows

What we designed

An agentic AI layer inside the Veeva workflow

We didn't propose replacing Veeva, and we didn't propose replacing reviewers. We designed AI agents to handle the repetitive 80% — drafting, checking, tagging, logging — so humans only touch decisions that need judgment.

Pillar A
AI-Powered Content Creation

Generative AI drafts HCP emails, detailing aids, and meeting summaries from pre-approved brand libraries — contextualized per therapeutic area, HCP segment, and region, with version control aligned to global brand guidelines.

Pillar B
Accelerated MLR Review

AI compliance guardrails flag prohibited terms, off-label claims, and missing references before submission. Reviewers see auto-tagged risk areas instead of full documents, and parallel workflows let medical, legal, and regulatory work simultaneously.

Pillar C
Adoption That Sticks

Targeted business-unit training and UAT workshops built into the rollout — because automation nobody uses is just expensive shelfware. Industry data shows 80%+ adoption within 6 months when this is done right.

Quest AI Orchestration Engine Powers every AI-automated stage below
Quest AI Layer Active
01
Human
Request

A brand or field team raises a content need.

Workflow Routing
02
AI Agent
AI Draft

Agents generate copy from approved brand libraries.

Content Generation
03
AI Agent
Compliance Check

Auto-validation against FDA, EMA, and GDPR rules.

Risk Detection
04
Human + AI
Reviewer Approval

MLR teams review pre-tagged risk areas in parallel.

Human Oversight
05
Automated
Veeva Deployment

Approved content goes live, with a full audit trail.

Enterprise Deployment
Workflow Routing Content Generation Risk Detection Compliance Validation Human Oversight Audit Trail Enterprise Deployment

ROI & competitive benchmarks

The combined impact, line by line

Where Teva stands today, what the pilot changes, what the rest of the industry has already published — and what each line is worth.

Category Current state With automation (pilot) Industry benchmark ROI for Teva
MLR approval cycle Slow, sequential approvals 40–50% cycle reduction — avg. 3–4 week cycles Pfizer: 35% faster approval cycles ~$200K annual savings per business unit
Speed to market Weeks lost in review delays; generics face erosion risk Launches 2–3 weeks faster, content live sooner Novartis: 50% faster content availability · Sanofi: 20% higher HCP engagement Each week saved on a high-value launch = $1M+ potential revenue
Compliance risk Manual re-submissions; risk of audit findings AI compliance guardrails + automated audit trails Eli Lilly: 70% drop in resubmissions after automation Lower risk of fines, rework, and reputational damage
Change management Manual processes; adoption challenges Targeted BU training + UAT workshops = smooth adoption Industry avg.: 80%+ adoption within 6 months ROI actually realized — no shelfware effect
Competitive positioning Lagging behind automation leaders AI-enabled workflows live in pilot BU Pfizer, Novartis & Sanofi have already scaled automation Parity with leaders at a leaner cost base

Pilot-stage impact model prepared for Teva Pharmaceuticals, Sept 2025. Industry figures from published implementations.

How we deliver — every engagement

Pilot first. Prove it. Then scale.

Enterprise AI fails when it launches everywhere at once. Our delivery model starts small on purpose — one business unit, a sandbox, clear KPIs — and earns each expansion. It's the same playbook whether you're in pharma, finance, or logistics.

  1. 01
    Discovery phase

    Requirement analysis & alignment

    Workshops with every stakeholder group — for Teva, that meant medical, legal, marketing, and IT — to define what "fast and compliant" actually means.

  2. 02
    Pilot deployment

    Pilot in one business unit

    AI workflows run in a sandbox against real content and real processes. Contained risk, honest results.

  3. 03
    System integration

    Workflow integration

    Pre-checks, parallel review, and audit automation go live with the teams who feel the bottleneck most.

  4. 04
    Business expansion

    Expansion

    The pilot's playbook scales across business units, regions, or therapeutic areas — tuned per context, not copy-pasted.

  5. 05
    Full enterprise deployment

    Enterprise rollout with dashboards

    Full deployment with Power BI / Tableau dashboards tracking cycle time, error rates, adoption, and ROI per asset.

Common questions

Enterprise AI, answered straight

What AI services does Quest GLT actually offer?

Six things: agentic AI workflow automation, generative AI content systems, AI compliance guardrails, custom AI assistants and chatbots, predictive analytics, and enterprise integration with platforms like Veeva, Salesforce, SAP, and Oracle. Most engagements combine two or three.

What is agentic AI, and how is it different from a chatbot?

A chatbot answers questions. Agentic AI completes work — it drafts the document, checks it against your rules, routes the approval, and logs the audit trail, across multiple steps, without waiting for a prompt at each one. Your people stay in the loop for decisions, not for repetition.

Can AI really automate content in regulated industries like pharma?

Yes — the leaders already publish their numbers. Pfizer cut initial content development time by 55% with AI-assisted creation. Eli Lilly saw a 70% drop in resubmissions after automation. Novartis reports 50% faster content availability. The trick is building compliance into the pipeline, not bolting it on after.

How much does a pilot cost, and what's the realistic ROI?

Pilots run in a single business unit over roughly one quarter. In the impact model we built for Teva, a single-BU pilot projects around $200K in annual savings — and on a high-value product launch, every week saved is worth $1M+ in potential revenue. We agree on KPIs before anything is built, so ROI is measured, not claimed.

How do you stop an AI project from becoming shelfware?

Change management is part of the build, not an afterthought. Targeted business-unit training, UAT workshops with the actual end users, and adoption tracked as a KPI alongside cycle time. Industry data shows 80%+ adoption within 6 months when rollouts are done this way — and near-zero when they aren't.

What systems can you integrate AI with?

Veeva CRM and Vault, Salesforce, SAP, Oracle, SharePoint, Box, Okta, Azure AD, Power BI, and Tableau — plus custom internal systems via API. The goal is one ecosystem where content, identity, pricing, and analytics never wait on a manual handoff.

Which manual process should stop being manual first?

Tell us where your workflows slow down. We'll map what an agentic AI pilot would look like in your environment — scope, timeline, and projected ROI — before you commit to anything.

Scroll